 |
市場調查報告書
商品編碼
1529022
鼻腔填塞裝置市場，副產品（注射劑、凝膠、噴霧劑、敷料）、類型（可生物吸收、不可吸收）、最終用途（醫院、診所、門診手術中心、家庭護理場所）- 2024 年至2032 年全球預測Nasal Packing Devices Market, By Product (Injectables, Gels, Sprays, Dressings), Type (Bioresorbable, Non-absorbable), End-use (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) - Global Forecast 2024 - 2032 |
||||||
由於設備技術的進步和鼻部疾病發生率的上升，2024年至2032年全球鼻腔填充設備市場的複合年成長率將達到5.2%。技術創新提高了鼻腔填塞解決方案的安全性、舒適性和有效性，滿足不斷變化的患者需求和偏好。此外，鼻竇炎等鼻部疾病病例的增加和術後護理需求的增加，也推動了對先進鼻填塞設備的需求。尖端技術和不斷成長的患者群體的結合確保了市場的持續擴張和更有效的鼻部治療解決方案的發展。
例如，2023 年 7 月，Aptar Pharma 推出了首款無金屬鼻噴泵 APF Futurity，旨在輸送鼻鹽水和類似的 OTC 製劑。這項創新旨在提高鼻腔治療的安全性和舒適度。這項創新反映了消除金屬部件以減少潛在過敏反應並提高用戶舒適度的日益成長的趨勢。透過專注於無金屬設計，Aptar Pharma 解決了安全性和患者體驗問題，有可能在市場上樹立新標準，並促使競爭對手採用類似的進步。
鼻腔填塞裝置產業根據產品、類型、最終用途和地區進行分類。
由於其易用性、患者舒適度和有效性，噴霧劑細分市場到 2032 年將經歷顯著成長。這些裝置可以快速緩解疼痛，並且比傳統的鼻填塞方法更不侵入性。噴霧劑受到醫療保健提供者和患者的青睞，因為它們能夠將藥物直接輸送到受影響的區域，減少併發症並促進更快的癒合。鼻部疾病的日益流行和噴霧技術的進步進一步推動了這一領域的主導地位。
在自我管理醫療保健趨勢不斷成長以及在家治療鼻部疾病的日益流行的推動下，家庭護理機構細分市場將在 2024 年至 2032 年間大幅成長。患者和照護者正在尋求使用者友好、有效的鼻填塞解決方案，這些解決方案可以在臨床環境之外輕鬆實施。居家護理設備的便利性，加上產品設計的進步，提高了可用性和舒適度，正在推動該細分市場的成長，反映出朝向更個人化和易於使用的護理選擇的轉變。
受國家醫療保健基礎設施快速擴張、鼻部健康意識增強以及呼吸系統疾病患病率上升的推動，亞太地區鼻腔填塞設備市場將在 2024 年和 2032 年呈現出可觀的複合年成長率。該地區人口眾多且多樣化，加上對醫療保健技術的投資不斷增加和醫療設施的改進，支持了對先進鼻腔填塞解決方案的需求。此外，家庭護理的日益普及和可支配收入的增加也促進了市場的成長，使亞太地區成為鼻腔填塞設備行業的主要貢獻者。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 鼻部疾病盛行率增加
- 鼻部手術數量不斷增加
- 老化人口基數不斷成長
- 重大技術進步
- 產業陷阱與挑戰
- 替代方案的可用性
- 與鼻填塞裝置相關的副作用
- 成長動力
- 成長潛力分析
- 技術景觀
- 監管環境
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司矩陣分析
- 公司市佔率分析
- 戰略展望矩陣
第 5 章：市場估計與預測：按產品分類，2021 - 2032 年
- 主要趨勢
- 注射劑
- 凝膠
- 噴霧劑
- 敷料
第 6 章：市場估計與預測：按類型，2021 - 2032
- 主要趨勢
- 可生物吸收
- 不可吸收
第 7 章：市場估計與預測：按最終用途，2021 - 2032 年
- 主要趨勢
- 醫院
- 診所
- 門診手術中心
- 家庭護理設置
- 其他最終用戶
第 8 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 9 章：公司簡介
- Aegis Lifesciences
- Boston Medical Products Inc.
- Cook
- FABCO
- Fannin Limited
- INNOVIA MEDICAL
- Lohmann & Rauscher GmbH & Co. KG
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- Network Medical Products Ltd.
- Olympus Corporation
- Smith & Nephew plc
- Stryker Corporation
- Summit Medical LLC.
- Teleflex Incorporated
Global Nasal Packing Devices Market will record a 5.2% CAGR from 2024 to 2032 due to advancements in device technology and the rising incidence of nasal disorders. Technological innovations enhance the safety, comfort, and efficacy of nasal packing solutions, addressing evolving patient needs and preferences. Also, increasing cases of nasal conditions, such as sinusitis and post-surgical care requirements, fuel demand for advanced nasal packing devices. This combination of cutting-edge technology and a growing patient base ensures continued market expansion and the development of more effective nasal treatment solutions.
For instance, in July 2023, Aptar Pharma introduced its first metal-free nasal spray pump, APF Futurity, designed for delivering nasal saline and similar OTC formulations. This innovation aims to enhance safety and comfort in nasal treatments. This innovation reflects a growing trend toward eliminating metal components to reduce potential allergic reactions and enhance user comfort. By focusing on metal-free design, Aptar Pharma addresses safety and patient experience concerns, potentially setting a new standard in the market and prompting competitors to adopt similar advancements.
The nasal packing devices industry is classified based on product, type, end-use, and region.
The sprays segment will experience marked growth through 2032, attributed to its ease of use, patient comfort, and effectiveness. These devices provide rapid relief and are less invasive than traditional nasal packing methods. Sprays are preferred by both healthcare providers and patients for their ability to deliver medication directly to the affected area, reducing complications and promoting faster healing. The increasing prevalence of nasal disorders and advancements in spray technology further drive this segment's dominance.
The home care settings segment will witness a substantial uptick between 2024 and 2032, propelled by the growing trend towards self-managed healthcare and the increasing prevalence of nasal conditions treated at home. Patients and caregivers are seeking user-friendly, effective nasal packing solutions that can be easily administered outside clinical settings. The convenience of home care devices, coupled with advancements in product design that enhance usability and comfort, is driving this segment's growth, reflecting a shift towards more personalized and accessible care options.
Asia Pacific nasal packing devices market will demonstrate a decent CAGR during 2024 and 2032, spurred by the nation's rapidly expanding healthcare infrastructure, increasing awareness about nasal health, and rising prevalence of respiratory conditions. The region's large and diverse population, along with growing investments in healthcare technology and improvements in medical facilities, supports the demand for advanced nasal packing solutions. Additionally, the increasing adoption of home-based care and rising disposable incomes contribute to market growth, making the Asia Pacific a key contributor to the nasal packing devices industry.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of nasal disorders
- 3.2.1.2 Rising number of nasal surgeries
- 3.2.1.3 Growing aging population base
- 3.2.1.4 Significant technological advancements
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Availability of alternatives
- 3.2.2.2 Side effects associated with nasal packing devices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Injectables
- 5.3 Gels
- 5.4 Sprays
- 5.5 Dressings
Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Bioresorbable
- 6.3 Non-absorbable
Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Clinics
- 7.4 Ambulatory surgical centers
- 7.5 Home care settings
- 7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Aegis Lifesciences
- 9.2 Boston Medical Products Inc.
- 9.3 Cook
- 9.4 FABCO
- 9.5 Fannin Limited
- 9.6 INNOVIA MEDICAL
- 9.7 Lohmann & Rauscher GmbH & Co. KG
- 9.8 Medtronic plc
- 9.9 Meril Life Sciences Pvt. Ltd.
- 9.10 Network Medical Products Ltd.
- 9.11 Olympus Corporation
- 9.12 Smith & Nephew plc
- 9.13 Stryker Corporation
- 9.14 Summit Medical LLC.
- 9.15 Teleflex Incorporated
